Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Darin Harper | Chief Financial Officer | 2025-06-24 | 134 | $31.86 | $4.27kSell |
Darin Harper | Chief Financial Officer | 2025-06-24 | 1,010 | $3.19k | $3.22MSell |
John Mulleady | SVP RE Dev | 2025-06-17 | 5,931 | $32.79 | $194.46kSell |
John Mulleady | SVP RE Dev | 2024-12-26 | 6,000 | $29.33 | $175.98kSell |
Kevin M. Sheehan | Interim CEO | 2024-12-19 | 19,025 | $26.45 | $503.12kBuy |
Hamish Dodds | Director | 2024-12-13 | 10,000 | $27.31 | $273.10kBuy |
Michael J. Griffith | Director | 2024-12-13 | 18,000 | $27.28 | $491.06kBuy |
Antonio Pineiro | SVP Chief Intl Dev Ofc | 2024-12-13 | 1,000 | $27.35 | $27.35kBuy |
Kevin M. Sheehan | Interim CEO | 2024-12-12 | 37,735 | $25.48 | $961.41kBuy |
Christopher Daniel Morris | Chief Executive Officer | 2024-10-07 | 14,912 | $33.68 | $502.16kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Hill Path D Fund LP | 20.60% | 7,124,015 | $214.29M | Insider |
Hill Path Capital Partners LP | 20.60% | 7,124,015 | $214.29M | Insider |
Hill Path Capital LP | 20.59% | 7,119,255 | $214.15M | Institution |
Blackrock Inc | 13.68% | 4,731,144 | $142.31M | Institution |
Vanguard Group Inc | 10.19% | 3,522,604 | $105.96M | Institution |
Eminence Capital LP | 8.40% | 2,905,454 | $87.40M | Institution |
Nomura Holdings Inc | 7.00% | 2,419,491 | $72.78M | Institution |
Patient Capital Management LLC | 6.37% | 2,201,507 | $66.22M | Institution |
Morgan Stanley | 4.36% | 1,506,768 | $45.32M | Institution |
Barrow Hanley Mewhinney Strauss LLC | 3.98% | 1,375,393 | $41.37M | Institution |